scispace - formally typeset
H

Holly A. Hill

Researcher at Centers for Disease Control and Prevention

Publications -  12
Citations -  1668

Holly A. Hill is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Intensive care unit & Staphylococcal infections. The author has an hindex of 9, co-authored 12 publications receiving 1608 citations.

Papers
More filters
Journal ArticleDOI

Prevalence of Staphylococcus aureus Nasal Colonization in the United States, 2001–2002

TL;DR: Many persons in the United States are colonized with S. aureus; prevalence rates differ demographically, and MRSA colonization prevalence, although low nationally in 2001-2002, may vary with demographic and organism characteristics.
Journal ArticleDOI

Methicillin-resistant–Staphylococcus aureus Hospitalizations, United States

TL;DR: The National Hospital Discharge Survey was used to calculate the number of US hospital discharges listing S. aureus–specific diagnoses, defined as those having at least 1 International Classification of Diseases (ICD)-9 code specific for S.aureus infection.
Journal ArticleDOI

The Effect of Vancomycin and Third-Generation Cephalosporins on Prevalence of Vancomycin-Resistant Enterococci in 126 U.S. Adult Intensive Care Units

TL;DR: This study studied the relationship between institutional characteristics (such as rates of nosocomial infection or antimicrobial use) and the prevalence of VRE in adult ICUs and questioned the importance of reducing vancomycin use in hospitalized populations as a control measure to reduce VRE.
Journal ArticleDOI

Temporal Changes in Prevalence of Antimicrobial Resistance in 23 U.S. Hospitals

TL;DR: Increases in resistance prevalence were significant only in isolates from patients outside intensive-care units (ICU) and are of concern; differences in factors present outside ICUs, such as excessive quinolone use or inadequate infection-control practices, may explain the observed trends.
Journal ArticleDOI

Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients.

TL;DR: In this study, antimicrobial cycling did not result in a significant change in enteric acquisition of resistant Gram-negative bacteria among intensive care unit patients.